Reg Alexander Lapham serves as Executive at Nemus Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Reg Alexander Lapham has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 13, 2017 involved exercising options for 119,700 shares valued at $119.7K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 13, 2017 | NMUS | $119.7K | Exercise | 119,700 | $1.00 | Discretionary |
Reg Alexander Lapham currently holds 3,787,500 shares of Nemus Bioscience, Inc. (NMUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Reg Alexander Lapham has been a net neutral trader of NMUS stock. They have purchased $0 and sold $0 worth of shares.
Reg Alexander Lapham's most recent insider trade was on Mar 13, 2017, when they sold 119,700 shares at $1.00 per share.
Get notified when new Form 4 filings are submitted